Narcolepsy

>

The NeurologyLive® Narcolepsy Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with the sleep disorder.

Latest News

Giuseppe Plazzi, MD, PhD  (Credit: Azienda USL di Bologna)
Interim Analysis Reveals Long-Term Efficacy and Safety of Pitolisant in Narcolepsy Types 1 and 2

May 13th 2025

A recent interim analysis of a 5-year observational study showed sustained benefit of pitolisant in reducing excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Crossover Trial Highlights Therapeutic Benefit of Daridorexant in Chronic Insomnia and Comorbid Nocturia
Crossover Trial Highlights Therapeutic Benefit of Daridorexant in Chronic Insomnia and Comorbid Nocturia

May 5th 2025

NeuroVoices: Adam S. Rappoport, MD, on Collaborative, Evolving Approaches in Pediatric Sleep Medicine
NeuroVoices: Adam S. Rappoport, MD, on Collaborative, Evolving Approaches in Pediatric Sleep Medicine

April 23rd 2025

Melissa Lipford, MD  (Credit: Mayo Clinic)
Real-World Data Show Similar Comorbidity Rates With and Without Sodium Oxybate Treatment

April 21st 2025

Akinyemi O. Ajayi, MD, FAAP, FCCP, D-ABSM, FAASM  (Credit: Orlando Magazine)
Post Hoc Analysis Shows Once-Nightly Sodium Oxybate Does Not Worsen Apnea-Hypopnea Index in Narcolepsy

April 5th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.